期刊文献+

双价痢疾工程疫苗经粘膜免疫动物的实验研究 被引量:6

The experimental study of two bivalent Shigella vaccines immunized mice in different mucosal route
原文传递
导出
摘要 目的 探讨不同粘膜免疫途径对 2株痢疾工程疫苗免疫效果的影响。方法 用FSM 2 1 1 7或FS 54 1 6以 4× 1 0 7CFU/只分别经滴鼻、灌胃和小肠内免疫小鼠 ,3次免疫后 7d分离小鼠脾、派伊尔结 (PP)、肠系膜中心淋巴结 (MLN)、小肠淋巴细胞固有层 (LPL)、鼻通道 (NP)及NALT淋巴细胞 ,用BA ELISASPOT法检测其特异性抗FSM 2 1 1 7或FS 54 1 6全菌抗原的IgA、IgG ASC(抗体分泌细胞 )数量。结果  2株疫苗经鼻内免疫都诱发了鼻粘膜相关淋巴组织、胃肠粘膜相关淋巴组织以及代表系统免疫反应的脾淋巴细胞全菌抗原特异性IgA、IgG ASC的显著增加 (P <0 .0 5和 0 .0 1 )。小肠内免疫后 ,可有效诱发肠粘膜局部以及脾淋巴细胞全菌抗原特异性IgA、IgG ASC的显著增加 (P <0 .0 1 ) ,但不能刺激鼻粘膜局部淋巴细胞的特异性ASC反应。结论  2株疫苗经鼻粘膜免疫均可诱导NALT和GALT及系统免疫反应的发生 ,是一个可行的免疫途径。 Objective To observe the effect of three different mucosal routes on the induction of immunogenicity of two bivalent Shigella vaccines. Methods BALB/c mice were divided into three groups with 10 in each. Mice were respectively immunized with Ipa + or Ipa - vaccines(4×10 7CFU) three doses with interval of two weeks by intranasal, intragastric or intraintestinal routes. The spleen, PP, MLN, LPL, NP, NALT lymphocytes were isolated on seventh day at random after last immunization. An BA ELISASPOT was done to quantify specific IgA or IgG ASC against bacteria pan antigen. Results The production of IgA and IgG ASC of spleen, GALT and NALT lymphocytes of intranasal group was significantly increased. In intraintestinal group, IgA and IgG ASC of spleen, GALT lymphocytes were significantly increased; but NALT lymphocytes did not increase. Conclusion Two bivalent Shigella vaccines can induce spleen immune response in NALT, GALT by intranasal inoculation. Only GALT but not NALT response was induced by intraintestinal inoculation.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2001年第5期523-526,共4页 Chinese Journal of Microbiology and Immunology
基金 国家"863"基金资助项目 ( 863 1 0 2 0 7 0 3 0 3)
关键词 痢疾疫苗 滴鼻免疫 灌胃免疫 肠内免疫 抗体分泌细胞 Bivalent Shigella vaccine Intranasal Intragastric Intraintestinal ASC
  • 相关文献

参考文献4

二级参考文献6

共引文献11

同被引文献86

  • 1蒋早立,李师永,黄敏君,黄松如.急性弓形虫感染小鼠腹腔巨噬细胞功能的变化[J].中国人兽共患病杂志,1994,10(3):17-19. 被引量:4
  • 2黄文,白杨,王继德,武金宝,李国锋,张卫民,周殿元.幽门螺杆菌热休克蛋白60脂质体疫苗的制备及其免疫预防作用[J].第一军医大学学报,2005,25(5):531-534. 被引量:7
  • 3王冠,沈叙庄.黏膜传递系统和黏膜佐剂研究进展[J].中华微生物学和免疫学杂志,2006,26(7):672-674. 被引量:2
  • 4张卓然.医学微生物学实验学[M].北京:科学出版社,2000.224.
  • 5Czyzewska A, Majkowska-Skrobek G. Discovering of mueosal immunity[J]. Pol Merkuriusz Lek, 2005, 19 (112) : 580 - 583.
  • 6Moyle PM, McGeary RP, Blanchflcld JT, et al. Mucosal immunization: adjuvants and delivery systems[J]. Curt Drug Deliv, 2004, 1 (4) :385 - 396.
  • 7Mestecky J, Michalek SM, Moldoveanu Z, et al. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans[J]. Behring Inst Mitt, 1997, 2 (98) : 33 -43.
  • 8Wu HY, Nguyen HH, Russell MW. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site [ J ]. Seand Immunol, 1997, 46(5) : 506 -513.
  • 9Sha Z, Kang SM, Compans RW. Mueosal immunization of CD4 + T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions[J]. Virology, 2005, 331(2) : 387 -395.
  • 10Yasuda Y, Isaka M, Taniguchi T, et al. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)- containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mueosal immune responses in the presence of anti-rCTB antibodies[JJ. Vaccine, 2003, 21 (21 - 22) : 2954 - 2963.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部